Hybrid decentralized clinical trials improve access in community settings, suggesting a new model for equitable cancer research.
hDCTs are feasible in community settings beyond traditional healthcare networks and can expand trial access by reducing logistical and financial burdens. The LCCC model offers a scalable framework to promote equity in cancer research.
No takes yet. Share an insight, caveat, or question.
Morrison et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: